Cargando…

1253. Optimization of empiric gram-negative infections with the combination antibiogram

BACKGROUND: Anti-pseudomonal beta-lactam drugs such as aztreonam (AZR), cefepime (CEF), piperacillin-tazobactam (P/T), meropenem (MER) are drugs used for empiric gram-negative (GN) infections. They are used with other drugs as empiric combination therapy (CT) for patients with sepsis. The antibiogra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Anthony K, Harrington, Susan, Dumford, Donald, Shrestha, Kasturi, Mistry, Bhavin, wong, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677053/ http://dx.doi.org/10.1093/ofid/ofad500.1093

Ejemplares similares

1181. Use of the Combination Antibiogram in the Era of MDR Gram-Negative Pathogens
por: Klinker, Kenneth, et al.
Publicado: (2018)

356. Impact of CLSI Breakpoint Changes on Unit-Specific Combination Antibiograms for Gram-Negative Respiratory Isolates
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

Inhibition and Reduction of Biofilm Production along with Their Antibiogram Pattern among Gram-Negative Clinical Isolates
por: Shrestha, Ojaswee, et al.
Publicado: (2023)

162. The Genotypic Antibiogram: Using Results of Gram-Negative Antimicrobial Resistance Genes Identified via Rapid Blood Culture Identification Tests to Optimize Treatment of Enterobacterales Bloodstream Infections
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

2182. Harnessing Direct-from-Blood MALDI-TOF (DBM) and Local Blood Stream Infection (BSI) Antibiogram Data to Direct Optimal Therapy for Gram-Negative Rod (GNR) Bacteremia
por: Tischendorf, Jessica, et al.
Publicado: (2019)

1243. Acceptable susceptibility thresholds reported in hospital antibiograms for Gram-negative rod infections: a survey and contingent valuation study of infectious diseases providers
por: Hasegawa, Shinya, et al.
Publicado: (2023)

1515. Patient-Based Stratification of Weighted-Incidence Syndromic Antibiogram (WISCA) for Empiric Antibiotic Prescribing
por: Hebert, Courtney, et al.
Publicado: (2018)

1253. Healthcare-Associated Transmission of Burkholderia cepacia Complex Associated With Extrinsically Contaminated Nasal Spray
por: Tran, Dat, et al.
Publicado: (2018)

177. User Preferences for Visualization of Antibiogram Data in Clinical Practice for Empiric Prescription of Antibiotics
por: Vingino, Alexandria R, et al.
Publicado: (2021)

2808. Evaluation of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide empiric therapy in pneumonia cases
por: Skoglund, Erik, et al.
Publicado: (2023)

Evaluating Patient-Specific Antibiograms
por: Overly, Shannon, et al.
Publicado: (2017)

Comparison of an Emergency Department-Specific Antibiogram to Hospital Antibiogram: Influence of Patient Risk Factors on Susceptibility
por: Miller, Jessica, et al.
Publicado: (2017)

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections
por: Makharita, Rabab R, et al.
Publicado: (2020)

The Regional Antibiogram Is an Important Public Health Tool to Improve Empiric Antibiotic Selection, Stenotrophomonas maltophilia As A Case Example
por: Humphries, Romney, et al.
Publicado: (2017)

212. Effectiveness of Empirical Piperacillin/tazobactam Compared to Cefepime for Bloodstream Infection Caused by Gram-Negative Bacilli
por: Ho Lee, Young, et al.
Publicado: (2023)

489 Accuracy of Clinicians' Empiric Treatment Choices for Resistant Gram-Negative Uropathogens
por: Linsenmeyer, Katherine, et al.
Publicado: (2014)

103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
por: Klinker, Kenneth, et al.
Publicado: (2020)

548. Carbapenem-Resistant Acinetobacter baumannii Antibiotic Susceptibility Testing and Antibiogram Formation, Connecticut 2017–2019
por: Paranandi, Anu, et al.
Publicado: (2019)

Optimized β-Lactam Therapy Improves Survival in Carbapenem Non-Susceptible Gram-Negative Infections
por: Flynt, Lauren K, et al.
Publicado: (2017)

Prevalence and antibiogram of coagulase negative Staphylococci in bioaerosols from different indoors of a university in India
por: Kumari, Himani, et al.
Publicado: (2020)

2048. Antibiogram Use in Wisconsin Nursing Homes
por: Taylor, Lindsay N, et al.
Publicado: (2019)

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)
por: Huband, Michael D, et al.
Publicado: (2020)

1253. Antimicrobial Activity of Cefepime in Combination with Taniborbactam Against Clinical Isolates of Enterobacterales from 2018-2020 Global Surveillance
por: Hackel, Meredith, et al.
Publicado: (2021)

114. Implementation of an Empiric Organism Specific Guidelines for Gram-negative Bacteremia in conjunction with Rapid Diagnostic Testing
por: Bernice, Fidelia, et al.
Publicado: (2020)

1330. Development of a Pediatric Emergency Department (ED) Uropathogen Antibiogram and Empiric Urinary Tract Infection (UTI) Treatment Algorithm
por: Dass, Akshith M, et al.
Publicado: (2020)

Assessment of risk factors for inappropriate empiric antibiotic therapy in patients with Gram-negative sterile site infection complicated by sepsis or septic shock
por: Micek, Scott, et al.
Publicado: (2017)

1147. Improving Accessibility and Antibiotic Prescribing with an Enhanced Digital Antibiogram
por: Yarahuan, Julia K, et al.
Publicado: (2019)

392. Epidemiology and Treatment Outcome of Gram-Negative Polymicrobial, Gram-Positive Polymicrobial and Mixed Polymicrobial Prosthetic Joint Infection
por: Hooshmand, Babak, et al.
Publicado: (2019)

Comparative evaluation of methods for the detection of biofilm formation in coagulase-negative staphylococci and correlation with antibiogram
por: Shrestha, Lok Bahadur, et al.
Publicado: (2018)

354. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Gram-Negative Bacteria in Intensive Care Units (ICU)
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

138. Focused Outpatient Antibiograms: Time for Widespread Implementation?
por: Manandhar, Sabina, et al.
Publicado: (2020)

400 Beyond the Antibiogram: Using Monte Carlo Analysis to Optimize Institution-Specific Antipseudomonal Therapy
por: Tennant, Sarah, et al.
Publicado: (2014)

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
por: Livermore, P
Publicado: (2013)

607. Group B Streptococcus Resistance to Clindamycin: Regional Antibiogram Surveillance in Los Angeles County
por: Krug, Cary, et al.
Publicado: (2018)

200. Comparison of Clinical Outcomes among Patients Treated with Ceftriaxone 2 Grams versus 1 Gram Daily for Gram-Negative Bacteremia
por: Huynh-Phan, Ricky, et al.
Publicado: (2023)

906. Impact of Accelerate Rapid Diagnostic Technology on Time to Optimal Antimicrobial Therapy in Gram Negative Bloodstream Infection
por: Jung, Hye Lim, et al.
Publicado: (2022)

1253. Sex-on-Premise Venue (SOPV) Attendance Among Men Who Have Sex with Men (MSM) in Lima, Perú: Results From a Cross-Sectional Web-Based Survey
por: Lankowski, Alexander, et al.
Publicado: (2019)

1297. Design and Testing of an Interactive Module for Improving Understanding and Application of Institutional Antibiograms
por: MacDougall, Conan
Publicado: (2022)

Use of Local Antibiogram Data and Antimicrobial Importance Ratings to Select Optimal Empirical Therapies for Urinary Tract Infections in Dogs and Cats
por: Scarborough, Ri, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82ur4u2e1auoaimk9nnst37d6t